NASDAQ
Kaleido Biosciences, Inc. (KLDO) has a eps (diluted) of $-2.16 as of Friday, December 31, 2021. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.